title: Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation.
abstract: Alterations in DNA methylation patterns are one of the earliest and most common events in tumorigenesis. Overall levels of genomic methylation often decrease during transformation, but localized regions of increased methylation have been observed in the same tumors. We have examined changes in the methylation status of the muscle determination gene myoD, which contains a CpG island, as a function of oncogenic transformation. This CpG island underwent de novo methylation during immortalization of 10T1/2 cells, and progressively more sites became methylated during the subsequent transformation of the cells to oncogenicity. The greatest increase in methylation occurred in the middle of the CpG island in exon 1 during transformation. Interestingly, no methylation was apparent in the putative promoter of myoD in either the 10T1/2 cell line or its transformed derivative. The large number of sites in the CpG island that became methylated during transformation was correlated with heterochromatinization of myoD as evidenced by a decreased sensitivity to cleavage of DNA in nuclei by MspI. A site in the putative promoter also became insensitive to MspI digestion in nuclei, suggesting that the chromatin structural changes extended beyond the areas of de novo methylation. Unlike Lyonized genes on the inactive X chromosome, whose timing of replication is shifted to late S phase, myoD replicated early in S phase in the transformed cell line. Methylation analysis of myoD in DNAs from several human tumors, which presumably do not express the gene, showed that hypermethylation also frequently occurs during carcinogenesis in vivo. Thus, the progressive increase in methylation of myoD during immortalization and transformation coinciding with a change in chromatin structure, as illustrated by the in vitro tumorigenic model, may represent a common mechanism in carcinogenesis for permanently silencing the expression of genes which can influence cell growth and differentiation.
authors.affiliation: Department of Biochemistry and Molecular Biology, USC/Norris Cancer Center, School of Medicine, Los Angeles 90033-0800.
authors.forename: W M
authors.initials: WM
authors.lastname: Rideout
authors.forename: P
authors.initials: P
authors.lastname: Eversole-Cire
authors.forename: C H
authors.initials: CH
authors.lastname: Spruck
authors.forename: C M
authors.initials: CM
authors.lastname: Hustad
authors.forename: G A
authors.initials: GA
authors.lastname: Coetzee
authors.forename: F A
authors.initials: FA
authors.lastname: Gonzales
authors.forename: P A
authors.initials: PA
authors.lastname: Jones
mesh_terms: D044503:5-Methylcytosine; D000818:Animals; D001483:Base Sequence; D002453:Cell Cycle; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000378:metabolism; D003596:Cytosine / Q000031:analogs & derivatives* / Q000378:metabolism; D017931:DNA Primers / Q000737:chemistry; D004261:DNA Replication; D004742:Enhancer Elements, Genetic; D005786:Gene Expression Regulation; D006570:Heterochromatin / Q000378:metabolism*; D006801:Humans; D008745:Methylation; D051379:Mice; D008969:Molecular Sequence Data; D017570:MyoD Protein / Q000235:genetics*; D011401:Promoter Regions, Genetic; D015183:Restriction Mapping
chemical_list: D017931:DNA Primers; D006570:Heterochromatin; D017570:MyoD Protein; D044503:5-Methylcytosine; D003596:Cytosine